Zepbound's Weight Loss, Cardiometabolic Benefits Hold Up at 3 Years

(MedPage Today) -- SAN ANTONIO -- Patients with overweight or obesity lost an average one-fifth of their body weight with the highest dose of tirzepatide (Zepbound) and maintained that loss for more than 3 years, follow-up of a randomized trial...